PBK (31) Antibody sc-136026 from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) PBK expression predicts favorable survival in colorectal cancer patientsVirchows Archiv : an international journal of pathologyAugust 1, 2021Nagano-Matsuo A, Inoue S, Koshino A, Ota A, Nakao K, Komura M, Kato H, Naiki-Ito A, Watanabe K, Nagayasu Y, et al.

(2) Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarraysPloS oneJanuary 1, 2018Su TC, Chen CY, Tsai WC, Hsu HT, Yen HH, Sung WW, Chen CJ.prechemotherapy primary colorectal tumors. The antibody used was anti-human PBK/TOPK (PBK/TOPK antibody, sc-136026, 1:150 dilution, Santa Cruz Biotechnology). Immunoreactivity was analyzed by pathologists, using a previously

PBK (31) Antibody